Table 1 Clinical data of 285 samples of colorectal cancer
From: Prognostic relevance of melanoma antigen D1 expression in colorectal carcinoma
Number of cases (%) | |
|---|---|
Gender | |
Male | 183 (64.2) |
Female | 102 (35.8) |
Age (years) | |
≤ 50 | 111 (38.9) |
> 50 | 174 (61.1) |
Location | |
colon | 133 (46.7) |
rectal | 152 (53.3) |
Clinical Stage | |
I | 47 (16.5) |
II | 61 (21.4) |
III | 88 (30.9) |
IV | 89 (31.2) |
T classification | |
T1 | 20 (7.0) |
T2 | 44 (15.4) |
T3 | 124 (43.5) |
T4 | 97 (34.0) |
N classification | |
N0 | 123 (43.2) |
N1 | 90 (31.6) |
N2 | 72 (25.3) |
M classification | |
M0 | 196 (68.8) |
M1 | 89 (31.2) |
Pathologic Differentiation | |
Poor | 58 (20.4) |
Moderate | 205 (71.9) |
Well | 22 (7.7) |
Histological Types | |
Non-mucinous adenocarcinoma | 268 (94.0) |
mucinous adenocarcinoma | 17 (6.0) |
Vital status (at follow-up) | |
Alive | 173 (60.7) |
Death (All colorectal cancer-related) | 112 (39.3) |
Low expression | 161 (56.5) |
High expression | 124 (43.5) |